San Francisco / Moscow / Novosibirsk / Paris / Sokolova / Santiago / St. Petersburg / Lyon / Seattle / London / L.A. / /
Company
Kramarev S.A. / Bentham Science Publishers Ltd. / Wharton S.A. / X. J. Pharm / John Willey and Sons Ltd / monoclonal AB / HA / Zotova S.A. / Cox / Medline / /
Continent
Asia / /
Country
France / China / Guinea / Russia / United States / /
Currency
USD / / /
Event
FDA Phase / /
Facility
Russian Research Chemical Pharmaceutical Institute / University of Washington / Pasteur Institute / Z. Arch / Institute of Virology / Laboratory Medicine / Pharmaceutical Institute / /
IndustryTerm
treatment of hepatitis C / HCV therapy / sulfate products / chemical synthesis / treatment of alcoholic liver disease / pseudoparticle systems / treatment for 5 days during the illness / clinical therapeutic applications / chemical examination / alkyl amino / hydroxyl / dimethylamine / /
MarketIndex
MDCK / IFN / /
MedicalCondition
acute respiratory disease / Hurt / viral infection / HIV / naturally circulating influenza A / infectious bronchitis virus / cirrhosis / human infection / antigenically distinct influenza / hepatitis B / Marek disease virus / influenza A H3N2 / thus blocking infection / avian influenza A / H5 influenza virus / illness / seasonal influenza viruses / liver disease / acute bronchitis / acute hepatitis C / acute influenza infection / HCV acute infection / pneumonia / different H5 influenza viruses / hepatocellular carcinoma / ARB-resistant influenza / influenza A / respiratory infections / HCV / fever / viral infections / HCV infection / virus infection / community-acquired influenza / rimantadine-resistant influenza viruses / adamantine-resistant influenza A / influenza viruses / pathogenic influenza / infection / epidemic outbreak / chronic hepatitis / chronic infection / influenza B / both viral infections / parainfluenza type / B infection / otitis / flu / milder respiratory infection / rhinitis / hepatitis C / Virus The influenza / avian influenza / H5 influenza viruses / epidemics ARB / influenza virus / chronic respiratory infections / highly pathogenic avian influenza / highly pathogenic avian influenza H5N1 / influenza / acute respiratory diseases / human influenza A / different influenza / available influenza / disease / human influenza viruses / alcoholic liver disease / Ebola / SARS / millions infections / epidemic seasons / mixed epidemic community outbreak / ARB Against Avian Flu / recurrent illness / acute respiratory infections / respiratory disease / human influenza B / Chronic hepatitis C / infectious particles / /
MedicalTreatment
drug targeting / antiretroviral therapy / chemotherapy / /
Organization
University of Washington / Institute of Virology / 2Chemical and Pharmaceutical Institute / School of Medicine / International Congress / Russian Research Chemical Pharmaceutical Institute / US Federal Reserve / Russian National Congress / ARB administration / National Institute of Health / Pasteur Institute in St. Petersburg / /
Person
Michael Roberts / Jeff Krise / Drinevsky / V / Cheney / /
Untitled